Press release
Metastatic Cancer Drugs Market Report 2023-2032: Market Size, Growth, Future Prospects, Demand And Forecast | Pfizer Inc., Johnson and Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc
Metastatic Cancer Drugs Market
The Business Research Company's Metastatic Cancer Drugs Global Market Report 2023 identifies increasing prevalence of metastatic cancers as the major driver for the Metastatic Cancer Drugs market's growth in the forecast period. Metastatic cancer refers to an advanced stage of cancer that spreads to other body parts. The number of cases of metastatic cancer rises, this leads to the development of novel cancer medications for treating various types of metastatic cancer.
The global metastatic cancer drugs market size is expected to grow from $53.15 billion in 2022 to $55.28 billion in 2023 at a compound annual growth rate (CAGR) of 4.02%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of metastatic cancer drugs market is expected to reach $65.64 billion in 2027 at a CAGR of 4.39%.
Download Free Sample Of Metastatic Cancer Drugs Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11941&type=smp
Major competitors in the Metastatic Cancer Drugs market are Pfizer Inc., Johnson and Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc.
A key trend in the Metastatic Cancer Drugs market includes Product innovations. Major market players are concentrating their efforts on developing novel drugs to strengthen their position in the market. For instance, in January 2021, Daiichi Sankyo Company Limited a Japan-based pharmaceutical company, and AstraZeneca plc a British-Swedish pharmaceutical and biotechnology company were granted conditional approval in the European Union for the drug ENHERTU (trastuzumab deruxtecan) as a monotherapy for the treatment of HER2 positive metastatic breast cancer. The drug ENHERTU is considered a novel medicine to be approved for breast cancer in Europe with phase 2 single-arm data. This product is transforming the outcomes of patients suffering from HER2-positive metastatic breast cancer in the USA and Japan, and this approval in the EU will also enable to have greater benefits for this medicine to patients in the EU as well owing to the rising cases of cancers.
Read More On The Global Metastatic Cancer Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/metastatic-cancer-drugs-global-market-report
The Metastatic Cancer Drugs market is segmented -
1. By Drug Class: HER2 Inhibitors, Immune Checkpoints Inhibitors, PARP Inhibitors, Kinase Inhibitors, Other Drug Class.
2. By Cancer: Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, Other Cancers
3. By Treatment: Chemotherapy, Immunotherapy, Hormonal Therapy, Surgery, Other Treatments
4. By Route Of Administration: Intravenous, Intramuscular, Oral, Other Routes Of Administration
5. By End-Users: Hospitals, Specialty Clinics, Other End-Users
6. By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Metastatic Cancer Drugs market.
The Business Research Company's "Global Metastatic Cancer Drugs Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Metastatic Cancer Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11941
The Table Of Content For The Metastatic Cancer Drugs Market Include:
1. Executive Summary
2. Metastatic Cancer Drugs Market Characteristics
3. Metastatic Cancer Drugs Market Trends And Strategies
4. Metastatic Cancer Drugs Market - Macro Economic Scenario
……
32. Global Metastatic Cancer Drugs Market Competitive Benchmarking
33. Global Metastatic Cancer Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Metastatic Cancer Drugs Market
35. Metastatic Cancer Drugs Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic Cancer Drugs Market Report 2023-2032: Market Size, Growth, Future Prospects, Demand And Forecast | Pfizer Inc., Johnson and Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc here
News-ID: 3218121 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
